{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T04:34:05Z","timestamp":1771907645277,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10067-021-05712-9","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T18:02:50Z","timestamp":1617040970000},"page":"4741-4748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pleural effusion in psoriatic arthritis patients: a case series and review of the literature"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4280-9193","authenticated-orcid":false,"given":"Aliki I.","family":"Venetsanopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7330-5428","authenticated-orcid":false,"given":"Theodora E.","family":"Markatseli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrisoula","family":"Iliou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoi","family":"Tziortzioti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria I.","family":"Argyropoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2232-0326","authenticated-orcid":false,"given":"Alexandros A.","family":"Drosos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5193-2284","authenticated-orcid":false,"given":"Paraskevi V.","family":"Voulgari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"issue":"suppl II","key":"5712_CR1","doi-asserted-by":"publisher","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","volume":"64","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis 64(suppl II):ii14\u2013ii17. https:\/\/doi.org\/10.1136\/ard.2004.032482","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"5712_CR2","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/rheumatology\/33.9.834","volume":"33","author":"SM Jones","year":"1994","unstructured":"Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33(9):834\u2013839. https:\/\/doi.org\/10.1093\/rheumatology\/33.9.834","journal-title":"Br J Rheumatol"},{"issue":"5","key":"5712_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/ard.47.5.386","volume":"47","author":"JG Hanly","year":"1988","unstructured":"Hanly JG, Russell ML, Gladman DD (1988) Psoriatic spondyloarthropathy: a long term prospective study. Ann Rheum Dis 47(5):386\u2013393. https:\/\/doi.org\/10.1136\/ard.47.5.386","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5712_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/00000441-199810000-00003","volume":"316","author":"DD Gladman","year":"1998","unstructured":"Gladman DD (1998) Clinical aspects of the spondyloarthropathies. Am J Med Sci 316(4):234\u2013238. https:\/\/doi.org\/10.1097\/00000441-199810000-00003","journal-title":"Am J Med Sci"},{"issue":"6","key":"5712_CR5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ejim.2011.06.006","volume":"22","author":"A El Maghraoui","year":"2011","unstructured":"El Maghraoui A (2011) Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 22(6):554\u2013560. https:\/\/doi.org\/10.1016\/j.ejim.2011.06.006","journal-title":"Eur J Intern Med"},{"issue":"9","key":"5712_CR6","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1093\/rheumatology\/keaa062","volume":"59","author":"B Pittam","year":"2020","unstructured":"Pittam B, Gupta S, Harrison NL, Robertson S, Hughes DM, Zhao SS (2020) Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 59(9):2199\u20132206. https:\/\/doi.org\/10.1093\/rheumatology\/keaa062","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"5712_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ccm.2019.05.003","volume":"40","author":"AJ Esposito","year":"2019","unstructured":"Esposito AJ, Chu SG, Madan R, Doyle TJ, Dellaripa PF (2019) Thoracic manifestations of rheumatoid arthritis. Clin Chest Med 40(3):545\u2013560. https:\/\/doi.org\/10.1016\/j.ccm.2019.05.003","journal-title":"Clin Chest Med"},{"issue":"135","key":"5712_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/09059180.00008014","volume":"24","author":"M Shaw","year":"2015","unstructured":"Shaw M, Collins BF, Ho LA, Raghu G (2015) Rheumatoid arthritis-associated lung disease. Eur Respir Rev 24(135):1\u201316. https:\/\/doi.org\/10.1183\/09059180.00008014","journal-title":"Eur Respir Rev"},{"issue":"4","key":"5712_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10067-014-2652-9","volume":"34","author":"R Peluso","year":"2015","unstructured":"Peluso R, Iervolino S, Vitiello M, Bruner V, Lupoli G, Di Minno MN (2015) Extra-articular manifestations in psoriatic arthritis patients. Clin Rheumatol 34(4):745\u2013753. https:\/\/doi.org\/10.1007\/s10067-014-2652-9 Epub 2014 May 8","journal-title":"Clin Rheumatol"},{"issue":"11","key":"5712_CR10","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3 Epub 2011 Jul 29","journal-title":"Rheumatol Int"},{"issue":"1","key":"5712_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/RHU.0b013e31817de10b","volume":"15","author":"A Balbir-Gurman","year":"2009","unstructured":"Balbir-Gurman A, Guralnik L, Best LA, Vlodavsky E, Yigla M, Menahem Nahir A, Braun-Moscovici Y (2009) Accelerated pulmonary nodulosis and sterile pleural effusion in a patient with psoriatic arthropathy during methotrexate therapy: a case report. J Clin Rheumatol 15(1):29\u201330. https:\/\/doi.org\/10.1097\/RHU.0b013e31817de10b","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"5712_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/LBR.0000000000000031","volume":"21","author":"C Cudzilo","year":"2014","unstructured":"Cudzilo C, Aragaki A, Guitron J, Benzaquen S (2014) Methotrexate-induced pleuropericarditis and eosinophilic pleural effusion. J Bronchology Interv Pulmonol 21(1):90\u201392. https:\/\/doi.org\/10.1097\/LBR.0000000000000031","journal-title":"J Bronchology Interv Pulmonol"},{"key":"5712_CR13","doi-asserted-by":"publisher","first-page":"985914","DOI":"10.1155\/2013\/985914","volume":"2013","author":"H Ozkan","year":"2013","unstructured":"Ozkan H, Cetinkaya AS, Yildiz T, Bozat T (2013) A rare side effect due to TNF-alpha blocking agent: acute pleuropericarditis with adalimumab. Case Rep Rheumatol 2013:985914\u2013985912. https:\/\/doi.org\/10.1155\/2013\/985914","journal-title":"Case Rep Rheumatol"},{"issue":"5","key":"5712_CR14","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1097\/MJT.0b013e31826fc4d1","volume":"21","author":"N Annapureddy","year":"2014","unstructured":"Annapureddy N, Agarwal SK, Ammakkanavar N, Kanakadandi V, Sabharwal MS, Sanjani HP, Simoes P, Nadkarni GN (2014) Tumor necrosis factor inhibitor-induced serositis. Am J Ther 21(5):e166\u2013e168. https:\/\/doi.org\/10.1097\/MJT.0b013e31826fc4d1","journal-title":"Am J Ther"},{"issue":"10","key":"5712_CR15","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s00063-007-1104-6","volume":"102","author":"H Haake","year":"2007","unstructured":"Haake H, K\u00f6neke J, Amann K, Vom Dahl J, Janssen U (2007) Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis. Med Klin (Munich) 102(10):852\u2013857. https:\/\/doi.org\/10.1007\/s00063-007-1104-6","journal-title":"Med Klin (Munich)"},{"issue":"4","key":"5712_CR16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1378\/chest.08-0034","volume":"134","author":"J Abunasser","year":"2008","unstructured":"Abunasser J, Forouhar FA, Metersky ML (2008) Etanercept-induced lupus erythematosus presenting as a unilateral pleural effusion. Chest 134(4):850\u2013853. https:\/\/doi.org\/10.1378\/chest.08-0034","journal-title":"Chest"},{"issue":"116","key":"5712_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1183\/09059180.00001210","volume":"19","author":"A Manuel","year":"2010","unstructured":"Manuel A, Jones Q, Wiggins J (2010) Multiple pulmonary nodules in a male with psoriatic arthritis. Eur Respir Rev 19(116):164\u2013165. https:\/\/doi.org\/10.1183\/09059180.00001210","journal-title":"Eur Respir Rev"},{"issue":"1","key":"5712_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10067-011-1758-6","volume":"31","author":"N Sathi","year":"2012","unstructured":"Sathi N, Chikura B, Kaushik VV, Wiswell R, Dawson JK (2012) How common is methotrexate pneumonitis? A large prospective study investigates. Clin Rheumatol 31(1):79\u201383. https:\/\/doi.org\/10.1007\/s10067-011-1758-6","journal-title":"Clin Rheumatol"},{"issue":"10","key":"5712_CR19","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s10067-011-1765-7","volume":"30","author":"F Rondon","year":"2011","unstructured":"Rondon F, Mendez O, Spinel N, Ochoa C, Saavedra C, Penaranda E, Garcia-Valladares I, Espinoza LR, Iglesias-Gamarra A (2011) Methotrexate-induced pulmonary toxicity in psoriatic arthritis (PsA): case presentation and literature review. Clin Rheumatol 30(10):1379\u20131384. https:\/\/doi.org\/10.1007\/s10067-011-1765-7","journal-title":"Clin Rheumatol"},{"issue":"6","key":"5712_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fmed.2019.00238","volume":"23","author":"GE Fragoulis","year":"2019","unstructured":"Fragoulis GE, Nikiphorou E, Larsen J, Korsten P, Conway R (2019) Methotrexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: current concepts for the diagnosis and treatment. Front Med (Lausanne) 23(6):238. https:\/\/doi.org\/10.3389\/fmed.2019.00238","journal-title":"Front Med (Lausanne)"},{"issue":"6091","key":"5712_CR21","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/bmj.2.6091.867","volume":"2","author":"PA Walden","year":"1977","unstructured":"Walden PA, Mitchell-Weggs PF, Coppin C, Dent J, Bagshawe KD (1977) Pleurisy and methotrexate treatment. Br Med J 2(6091):867. https:\/\/doi.org\/10.1136\/bmj.2.6091.867","journal-title":"Br Med J"},{"issue":"2","key":"5712_CR22","first-page":"141","volume":"81","author":"P Palungwachira","year":"1998","unstructured":"Palungwachira P, Palungwachira P, Laohathai P (1998) Methotrexate induced pericarditis and pericardial effusion in psoriatic patient. J Med Assoc Thail 81(2):141\u2013145","journal-title":"J Med Assoc Thail"},{"issue":"2","key":"5712_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5070\/D33KC8K73Q","volume":"16","author":"F Savoia","year":"2010","unstructured":"Savoia F, Gaddoni G, Casadio C, Patrizi A, Spadola G, Bassi P, Albertini F, Ballardini G, Briganti E, Casolari S, De Don\u00e0 D, Menni B, Zanotti M, De Angelis P (2010) A case of aseptic pleuropericarditis in a patient with chronic plaque psoriasis under methotrexate therapy. Dermatol Online J 16(2):13","journal-title":"Dermatol Online J"},{"issue":"4","key":"5712_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","volume":"86","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Mu\u00f1oz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86(4):242\u2013251. https:\/\/doi.org\/10.1097\/MD.0b013e3181441a68","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"5712_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10067-017-3884-2","volume":"37","author":"O Shovman","year":"2018","unstructured":"Shovman O, Tamar S, Amital H, Watad A, Shoenfeld Y (2018) Diverse patterns of anti-TNF-\u03b1-induced lupus: case series and review of the literature. Clin Rheumatol 37(2):563\u2013568. https:\/\/doi.org\/10.1007\/s10067-017-3884-2","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5712_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1755-7682-5-7","volume":"5","author":"E Puertas-Abreu","year":"2012","unstructured":"Puertas-Abreu E, Polanco ER, Azocar M, Mundarain LA, Nu\u00f1ez-Sotelo CM, Monta\u00f1o R, Vivas FH, Noguera ZT, Mar\u00edn F, Bellorin O, Rivas JG, Toro E, Benzaquen E, Rauseo M, Guti\u00e9rrez Gonz\u00e1lez LA, GRUPO GRUVES: grupo Venezolano para el Estudio de las Espondiloartritis (2012) Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-\u03b1. Int Arch Med 5(1):7. https:\/\/doi.org\/10.1186\/1755-7682-5-7","journal-title":"Int Arch Med"},{"issue":"12","key":"5712_CR27","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1610-0387.2012.08000.x","volume":"10","author":"C Dalle Vedove","year":"2012","unstructured":"Dalle Vedove C, Simon JC, Girolomoni G (2012) Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNF\u03b1 agents. J Dtsch Dermatol Ges 10(12):889\u2013897. https:\/\/doi.org\/10.1111\/j.1610-0387.2012.08000.x","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05712-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05712-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05712-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T13:00:22Z","timestamp":1634389222000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05712-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5712"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05712-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"assertion":[{"value":"30 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This study was conducted in compliance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All patients gave written informed consent before clinical data collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}